Nanotechnology Now - Press Release: "Curcumin shows anti-colon cancer activity, NANOTEC researcher say"

Home > Press > Curcumin shows anti-colon cancer activity, NANOTEC researcher say

Dr.Ubonthip

Dr.Ubonthip

Abstract:
Researchers at National Nanotechnology Center (NANOTEC) have discovered that using a compound consisting of curcuminoids-succinate prodrugs can improve stability in phosphate buffer, releases curcumin derivatives in human plasma, and shows anti-colon cancer activities.

Curcumin shows anti-colon cancer activity, NANOTEC researcher say

Pathumthani, Thailand | Posted on May 18th, 2011

"According to Globocan 2002, colon cancer was the third most common malignant disease in Thai males, while it ranked fifth among Thai females" said Dr. Ubonthip Nimmannit, Head of NanoCosme Lab at NANOTEC. "The investigation involving the synthesis of curcuminoids as potential prodrug is of significant importance to local physicians as it suggests that succinylation of curcuminoids is stable and can release the parent curcumin derivatives in human plasma which makes it to be promising candidates for future treatment of colon cancer".

Colon cancers among Thai people are expected to increase, with about 5,000 new cases diagnosed nationwide every year. The contributing factor to this increase is the imbalanced and unhealthy diet including sedentary lifestyles can also contribute to the development of the disease.

Collaborators on this investigation included researchers from Chulalongkorn University. The researchers reported their investigation in a paper published by MDPI Molecules.

####

For more information, please click here

Contacts:
Ramjitti Indaraprasirt
Manager
International Relations Section
NANOTEC
02-564-7100 ext: 6617

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: